Answers are grounded in this paper and cite their sources.
Glypican 3 (GPC 3) is one of six glypicans identified in humans. Glypicans are external cell surface membrane-bound Heparan Sulfate Proteoglycans (HSPGs), anchored by a Glycosyl-Phosphatidylinositol (GPI). GPC 3 is a regulator of morphogens and growth factors in cell maturation during development. GPC 3 plays diverse roles in cancer and modulates various aspects of tumour biology. Its effects on cancer progression depend on the type of tissue involved. GPC 3 may serve as a tumour marker for cancer diagnosis and may also be a viable target for cancer therapy. Here, we review the expression, localization, mutations, and functional roles of GPC 3 during the pathogenesis and progression of various human cancers.
No takes yet. Share an insight, caveat, or question.
Omid Iravani (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: